Talk:Modafinil/GA3: Difference between revisions – Wikipedia

Article (edit | visual edit | history) · Article talk (edit | history) · Watch

Nominator: Maxim Masiutin (talk · contribs) 21:24, 23 December 2024 (UTC)[reply]

Reviewer: Czarking0 (talk · contribs) 16:40, 1 February 2026 (UTC)[reply]

StartCzarking0 (talk) 16:40, 1 February 2026 (UTC)[reply]

Nom is #1 author with >40% of the content written.Czarking0 (talk) 16:41, 1 February 2026 (UTC)[reply]

Earwig results look fine to me.Czarking0 (talk) 16:51, 1 February 2026 (UTC)[reply]

Organization

• I think the “Society and culture” section is poorly named. The paragraph with Modafinil’s use varies by region. and the subsequent one should be included in that section. This seems like the sort of thing that could be better communicated with a map?Czarking0 (talk) 16:53, 1 February 2026 (UTC)[reply]
• The occupational section is not in summary style. The information can be accomplished with two or three sentences.Czarking0 (talk) 17:14, 1 February 2026 (UTC)[reply]

Sources

Length

I do not immediately dismiss this based on length. It is at 6-7 thousand words readable prose size. That might be fine. However, I do look for statements to remove.

• Given its approved status in the US to treat narcolepsy, physicians can also prescribe modafinil for off-label uses, such as treating ADHD in both children and adults. This is overly US focused and is a general statement about how off-label use works in the US rather than a claim about the article subject.Czarking0 (talk) 17:07, 1 February 2026 (UTC)[reply]
• The Canadian Network for Mood and Anxiety Treatments (CANMAT) As a more general point, this is functioning as an attribution rather than an important regional claim. If the regional claim was the important part then my advice is to simply the article by dedicating a section to regional variation and then not making regional points elsewhere. If this should merely function as an attribution I recommend reworking it so it does not need attribution and combining info with rest of section.Czarking0 (talk) 17:07, 1 February 2026 (UTC)[reply]
• 2021 meta-analysis concluded that attribution not needed, I’ll stop this comment but my point is to give the whole thing a pass over to remove places where MEDRS yield an unnecessary attribution. Czarking0 (talk) 17:08, 1 February 2026 (UTC)[reply]
• The effectiveness of modafinil as a cognitive enhancer is still debated. Some studies suggest significant increases in cognitive abilities, while others indicate mild to nonexistent cognitive improvements. Either the first sentence or the second is redundant depending on how much detail you feel is important
• No significant changes in body weight have been observed in clinical trials, although decreased appetite and weight loss have been noted in children and adolescents. Certainly you do not plan to list all the side effects that do not occur? What is the point of this statement?Czarking0 (talk) 17:17, 1 February 2026 (UTC)[reply]

Writing

• required Cephalon Who is cephalon?